Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Low detectable PSA after prostatectomy – watch or treat? | THE "NEW" PROSTATE CANCER INFOLINK
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
A non–conformity approach towards post-prostatectomy metastasis estimation using a multicenter prostate cancer database
Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library
Pathological predictors of 18F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy - Perry - 2022 - BJU International - Wiley Online Library
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports
Salvage Radiation Therapy Nomograms | Dan's Journey through Prostate Cancer
El tiempo de doblaje de PSA como nuevo método diagnóstico y pronóstico del cáncer de próstata
PSA Doubling Time Calculator
PSA doubling time | Dan's Journey through Prostate Cancer
CUAJ – Review Danielson et al Management of non-metastatic prostate cancer Management algorithms for prostate-specific antigen
PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
IJTM | Free Full-Text | Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study
Month 134 – PSA Results | Dan's Journey through Prostate Cancer
Calculadoras – Urología Basada en Evidencia
Oncology Resources - EOS | Emirates Oncology Society
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Calculadoras – Urología Basada en Evidencia
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
![Tomography | Free Full-Text | [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients](https://pub.mdpi-res.com/tomography/tomography-08-00226/article_deploy/html/images/tomography-08-00226-g002.png?1667648844 "Tomography | Free Full-Text | [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients")
Tomography | Free Full-Text | [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer
PDF) Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
Full article: Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: A single-centre experience
![Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-021-00869-5/MediaObjects/13550_2021_869_Fig1_HTML.png "Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging | EJNMMI Research | Full Text")